NSE ScannerComparison · NSE · data 2026-10-31
Panacea Biotec Limited vs Venus Remedies Limited
In plain words
Size: Panacea Biotec Limited is about 1.2 times the market value of Venus Remedies Limited.
Return on equity: Venus Remedies Limited 16.8% vs Panacea Biotec Limited -0.6%.
Debt to equity: Panacea Biotec Limited 0.03 vs Venus Remedies Limited 0.02.
Differences in the numbers, not a recommendation of either stock.
Side by side
| PANACEABIO | VENUSREM | |
|---|---|---|
| Price | ₹313.25 | ₹1,238.6 |
| Market cap | ₹1,917 cr | ₹1,646 cr |
| P/E | — | 13.6 |
| P/B | — | 2.4 |
| ROE | -0.6% | 16.8% |
| ROCE | -6.3% | 14.5% |
| Debt / equity | 0.03 | 0.02 |
| Operating margin | -4.5% | 17.7% |
| Dividend yield | 0.00% | 0.81% |
| Sales growth, 3 years (yearly) | 10.1% | 10.1% |
| Profit growth, 3 years (yearly) | — | 57.0% |
| 1-year return | -29.8% | 182.9% |
| Revenue, last 12 months | ₹673 cr | ₹837 cr |
| Net profit, last 12 months | ₹-7 cr | ₹122 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹2 cr | ₹26 cr |
| Quarter profit vs a year earlier | -43.2% | +27.4% |
| Promoter holding | 72.48% | 41.76% |
| Health check | Weak (0.8/10) | Strong (8/10) |
Common questions
Which earns a higher return on equity?
Venus Remedies Limited (16.8% against -0.6%).
Which carries more debt?
Panacea Biotec Limited has the higher debt-to-equity ratio (0.03 against 0.02).